GENE ONLINE|News &
Opinion
Blog

Breast Cancer
AACR 2024 Breast CancerAACR 2024
AACR Showcases Breakthroughs in Novel Breast Cancer Diagnosis and Treatment Strategies
2024-04-09
Partnerships Oncology
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Trials & Approvals Breast Cancer
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Trials & Approvals Breast Cancer
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
Trials & Approvals Breast Cancer
Action Date Set for Gilead Sciences’ HR+/HER2- breast cancer sBLA
2022-10-11
Trials & Approvals HER2
Roche’s Newly Approved Companion Diagnostic May Open Treatment Options for HER2-low Patients
2022-10-06
Trials & Approvals Breast Cancer
AstraZeneca and Merck’s HER2-negative Breast Cancer Treatment Wins Yet Another Approval
2022-08-25
Trials & Approvals Oncology
Sanofi Abandons SERD Candidate After Second Breast Cancer Clinical Trial Blow
2022-08-18
Licensing Gilead Sciences
Gilead Forking Over $280 million to Everest to Regain Rights to Breast Cancer Treatment
2022-08-16
Trials & Approvals Breast Cancer
Gilead’s New Chemotherapy for Metastatic Breast Cancer Demonstrates Increase in Overall Survival
2022-08-15
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
Trials & Approvals Cancer Vaccine
Amazon, Fred Hutchinson Begin Human Trial for Cancer Vaccine
2022-07-14
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
China Breast Cancer
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
1 2 3 4
LATEST
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top